Advertisement

ADVERTISEMENT

Interventional oncology

News
Surefire Receives Regulatory Approval for Infusion Systems and Guiding Catheters in Mexico
03/20/2017
WESTMINSTER, Colo., March 20, 2017 (GLOBE NEWSWIRE) -- Surefire Medical, Inc., the developer of site-specific delivery devices for the Interventional Oncology market, announced today that the company has received regulatory approval in Mexico...
WESTMINSTER, Colo., March 20, 2017 (GLOBE NEWSWIRE) -- Surefire Medical, Inc., the developer of site-specific delivery devices for the Interventional Oncology market, announced today that the company has received regulatory approval in Mexico...
WESTMINSTER, Colo., March 20,...
03/20/2017
IO Learning
Q&A With CIO Course Director Ripal Gandhi, MD
03/20/2017
Clinical Interventional Oncology Course Director Ripal Gandhi, MD, Miami Cardiac and Vascular Institute (MCVI), shared his thoughts on the 9th annual Symposium in Hollywood Florida, Feb. 4-5, 2017. Tell us about the growing importance of IO...
Clinical Interventional Oncology Course Director Ripal Gandhi, MD, Miami Cardiac and Vascular Institute (MCVI), shared his thoughts on the 9th annual Symposium in Hollywood Florida, Feb. 4-5, 2017. Tell us about the growing importance of IO...
Clinical Interventional Oncology...
03/20/2017
IO Learning
Combination Interventional Therapy for Hepatocellular Carcinoma
03/17/2017

Karen Brown, MD, FSIR
Memorial Sloan Kettering Cancer Center, New York, New York

Karen Brown, MD, FSIRMemorial Sloan K...
Many interventional oncologists are exploring combined therapies for solitary hepatocellular cancer (HCC). The outcome of combining transarterial chemoembolization (TACE) and ablation has been reported, including two randomized, controlled...
Many interventional oncologists are exploring combined therapies for solitary hepatocellular cancer (HCC). The outcome of combining transarterial chemoembolization (TACE) and ablation has been reported, including two randomized, controlled...
Many interventional oncologists...
03/17/2017
IO Learning
Interview
Interventional Oncology Year in Review
03/17/2017

Nadine Abi-Jaoudeh, MD
School of Medicine, University of California, Irvine, Irvine, California

Nadine Abi-Jaoudeh, MDSchool of Medic...
This past year has been marked by the completion of some long-awaited studies that led to a number of surprises. In February 2016, Dr Brown’s prospective, randomized study comparing doxorubicin-loaded beads vs bland beads for hepatocellular...
This past year has been marked by the completion of some long-awaited studies that led to a number of surprises. In February 2016, Dr Brown’s prospective, randomized study comparing doxorubicin-loaded beads vs bland beads for hepatocellular...
This past year has been marked...
03/17/2017
IO Learning
As Interventional Oncology Evolves, So Does CIO
03/16/2017

Shaun Samuels, MD
Baptist Hospital of Miami, Miami, Florida

Shaun Samuels, MDBaptist Hospital of ...
Interventional oncology (IO) represents the possibility of a paradigm shift in cancer therapy. Replacing surgical therapy with non-surgical options for cure, and challenging the orthodoxy of systemic chemotherapy for the control of...
Interventional oncology (IO) represents the possibility of a paradigm shift in cancer therapy. Replacing surgical therapy with non-surgical options for cure, and challenging the orthodoxy of systemic chemotherapy for the control of...
Interventional oncology (IO)...
03/16/2017
IO Learning
CIO Spotlight: Dr Tam on the Role of Biopsy in 2017
02/19/2017

Alda L. Tam, MD, FRCPC, MBA 

Alda L. Tam, MD, FRCPC, MBA 
Alda Tam, MD Dr Alda Tam presented the session Understanding the Role of Biopsy at the 2017 Clinical Interventional Oncology Symposium. In this article, Dr Tam provides the reader with a full deciphering of her presentation. Here she...
Alda Tam, MD Dr Alda Tam presented the session Understanding the Role of Biopsy at the 2017 Clinical Interventional Oncology Symposium. In this article, Dr Tam provides the reader with a full deciphering of her presentation. Here she...
Alda Tam, MD Dr Alda Tam...
02/19/2017
IO Learning
Interview
Interventional Oncology 2016: The State of the Union Is Good!
11/04/2016

Daniel B. Brown, MD, FSIR
From Vanderbilt University, Nashville, Tennessee.

 

Daniel B. Brown, MD, FSIRFrom Vanderb...
Interventional Radiology (IR) has had a historic year, receiving the first new primary specialty designation awarded by the American Board of Medical Specialties in over 25 years. In parallel, the University of Miami took the extraordinary...
Interventional Radiology (IR) has had a historic year, receiving the first new primary specialty designation awarded by the American Board of Medical Specialties in over 25 years. In parallel, the University of Miami took the extraordinary...
Interventional Radiology (IR)...
11/04/2016
IO Learning
Interview
Interventional Oncology at ASCO 2016
06/20/2016
The American Society of Clinical Oncology (ASCO) was held, as it has been every year, at McCormick Place in Chicago, Illinois, from June 3 to 7, 2016. As the world's largest oncology-focused meeting, it was an honor and a pleasure to attend...
The American Society of Clinical Oncology (ASCO) was held, as it has been every year, at McCormick Place in Chicago, Illinois, from June 3 to 7, 2016. As the world's largest oncology-focused meeting, it was an honor and a pleasure to attend...
The American Society of Clinical...
06/20/2016
IO Learning
Clinical Insights
The Center for Interventional Oncology at the National Institutes of Health: An Interview With Bradford Wood, MD
04/01/2016

Interview by Jennifer Ford

Interview by Jennifer Ford
Bradford Wood, MD, is director of the Center for Interventional Oncology, chief of interventional radiology, and a senior researcher with the National Institutes of Health (NIH). The Center for Interventional Oncology is a collaboration among...
Bradford Wood, MD, is director of the Center for Interventional Oncology, chief of interventional radiology, and a senior researcher with the National Institutes of Health (NIH). The Center for Interventional Oncology is a collaboration among...
Bradford Wood, MD, is director...
04/01/2016
IO Learning
News
Ablynx to Receive 8 Million Euro Milestone as Boehringer Ingelheim Starts First Patient Study With Bi-Specific Nanobody in Oncology
01/29/2016
January 29, 2016 01:06 ET | Source: AblynxGHENT/ZWIJNAARDE, Belgium, Jan. 29, 2016 (GLOBE NEWSWIRE) -- Ablynx today announced that Boehringer Ingelheim has administered the first dose in a Phase I dose escalation study with the half-life...
January 29, 2016 01:06 ET | Source: AblynxGHENT/ZWIJNAARDE, Belgium, Jan. 29, 2016 (GLOBE NEWSWIRE) -- Ablynx today announced that Boehringer Ingelheim has administered the first dose in a Phase I dose escalation study with the half-life...
January 29, 2016 01:06 ET |...
01/29/2016
IO Learning

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 18 ⁠–⁠ September 20
September 20 ⁠–⁠ September 22
September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use